Position in JNJ
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$44,581,211
-$5,414,597 QoQ
Shares Held
182,381
-24.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Employees Provident Fund Board holds $1,134,862,339 across 8 Drug Manufacturers - General names. JNJ ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
524,361 | $482,291,516 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,895,165 | $227,969,397 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
2,509,000 | $152,170,850 | |
| 4 | BIIB |
Biogen Inc.
|
704,196 | $129,100,252 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
346,000 | $48,222,020 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
182,381 | $44,581,211 | |
| 7 | ABBV |
AbbVie Inc.
|
145,134 | $31,565,193 | |
| 8 | AMGN |
Amgen Inc
|
53,892 | $18,961,900 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,581,211 | 182,381 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $49,995,808 | 241,584 | Shares | Sole | 2026-03-03 | |
| 2025-09-30 | $44,789,498 | 241,557 | Shares | Sole | 2026-03-17 | |
| 2025-06-30 | $35,208,875 | 230,500 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $16,430,763 | 99,076 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $16,631,300 | 115,000 | Shares | Sole | 2026-03-17 | |
| 2024-09-30 | $14,342,310 | 88,500 | Shares | Sole | 2026-03-17 | |
| 2024-06-30 | $13,987,512 | 95,700 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $13,683,435 | 86,500 | Shares | Sole | 2026-03-18 | |
| 2023-12-31 | $13,322,900 | 85,000 | Shares | Sole | 2026-03-18 | |
| 2023-09-30 | $12,615,750 | 81,000 | Shares | Sole | 2026-03-18 | |
| 2023-06-30 | $9,914,648 | 59,900 | Shares | Sole | 2026-03-31 | |
| 2023-03-31 | $7,767,980 | 50,116 | Shares | Sole | 2026-03-18 | |
| 2022-12-31 | $2,711,577 | 15,350 | Shares | Sole | 2026-03-18 | |
| 2022-09-30 | $2,826,128 | 17,300 | Shares | Sole | 2026-03-18 | |
| 2022-06-30 | $1,899,357 | 10,700 | Shares | Sole | 2026-03-18 | |
| 2022-03-31 | $921,596 | 5,200 | Shares | Sole | 2026-03-18 | |
| 2021-12-31 | $718,494 | 4,200 | Shares | Sole | 2026-03-18 | |
| 2021-06-30 | $46,986,483 | 285,216 | Shares | Sole | 2026-03-18 | |
| 2021-03-31 | $46,875,249 | 285,216 | Shares | Sole | 2026-03-18 | |
| 2020-12-31 | $59,849,725 | 380,288 | Shares | Sole | 2026-03-18 | |
| 2020-09-30 | $53,876,396 | 361,878 | Shares | Sole | 2026-03-20 | |
| 2020-06-30 | $47,775,245 | 339,723 | Shares | Sole | 2026-03-31 | |
| 2020-03-31 | $11,302,094 | 86,190 | Shares | Sole | 2026-03-20 | |
| No filing history on record for this holder in this stock. | ||||||